Kantos Master (Formoterol Fumarate Dihydrate, Beclometasone Dipropionate Anhydrous)

Formoterol fumarate is a long‑acting β2‑adrenergic agonist. It binds to β2 receptors on airway smooth‑muscle cells, activating adenylate cyclase and increasing cyclic AMP levels, which leads to relaxation of the bronchial smooth muscle and prolonged bronchodilation for up to 12 hours, improving airflow in obstructive airway diseases.

Beclometasone dipropionate is an inhaled corticosteroid that penetrates airway cells and binds to glucocorticoid receptors. This interaction modulates gene transcription, suppressing the production of inflammatory cytokines, reducing airway edema, mucus secretion, and hyper‑responsiveness, thereby providing anti‑inflammatory control of asthma and COPD.

The specific dose and inhalation schedule for Kantos Master are determined by the prescribing healthcare professional based on the severity of the disease, patient age, and response to therapy. Patients should follow the prescriber’s instructions and the device’s dosing counter, and never adjust the dose without medical advice.

The safety of Kantos Master in pregnancy and lactation has not been fully established, and the product carries an unknown pregnancy category. Clinicians should weigh the potential benefits against possible risks, and pregnant or nursing women should discuss treatment options with their healthcare provider before using this inhaler.

To place an enquiry, visit the product page on gnhindia.com, enter the required quantity, and submit the request. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Kantos Master contains the same active ingredients—formoterol and beclometasone—as many other licensed combination inhalers, offering comparable efficacy in reducing symptoms and exacerbations. Differences may lie in device design, dose strength, and regional regulatory approvals; clinicians choose a product based on patient preference, inhaler technique, and local formularies.

Kantos Master should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and heat. Keep the inhaler away from direct sunlight and do not expose it to freezing conditions. Ensure the mouthpiece remains clean and replace the canister according to the manufacturer’s expiration date.

The patient should remove the cap, shake the inhaler gently, and exhale fully away from the device. Press down on the canister to release a metered dose while beginning a slow, steady inhalation, then hold the breath for about 10 seconds before exhaling. Rinse the mouth after each use to reduce the risk of oral thrush.

Kantos Master is contraindicated in patients with a known hypersensitivity to formoterol, beclometasone, or any excipients in the inhaler. It should also be avoided in individuals who have experienced a severe paradoxical bronchospasm with LABA therapy. Patients with uncontrolled cardiovascular disease should use it only under close medical supervision.